Althea offers cGMP plasmid production, protein production, formulation and filling services. Plasmid DNA and protein production are offered using both Althea’s industry-leading manufacturing process as well as client developed processes. A range of options are available for formulation and filling services ranging from semi- automated to fully- automated processes for vials and syringes. Althea is focused on offering highly responsive customer service, flexible scheduling, and rapid turnaround times to meet the requirements of both early stage clinical programs and commercial programs alike.
Althea Names Alan Moore as Executive Vice President and Chief Business Officer
SAN DIEGO - October 8, 2003 - Althea Technologies, Inc., a leading provider of gene-based manufacturing and testing services to accelerate drug development, announced today that Alan Moore has joined the company as Executive Vice President and Chief Business Officer. In his role, Mr. Moore will be focusing on strategies to continue increasing Althea's sales, as well as to seek corporate collaborations to further extend the value of Althea's technologies.
"We are extremely pleased to have such a well-respected leader in the contract service industry join Althea," stated Dr. Francois Ferre, Co-President and Co-CEO of Althea. "Alan brings a strong track record in assisting growing companies step to the next level. His knowledge of the industry and his ability to build strategic business alliances with pharmaceutical and biotech companies, as well as with governmental agencies, will be very beneficial as we expand the uses of our technologies."
Mr. Moore brings over twenty years of experience in the biopharmaceutical industry. Prior to joining Althea, he was General Manager of Biopharmaceutical Development Services at Charles River Laboratories in Rockville, Maryland, and before that, he was President of Genzyme Transgenics Washington Laboratories. He also served as Director of Business Development for Microbiological Associates (BioReliance). Mr. Moore's experience includes development of corporate sales and business development strategies, including building strong international relationships. He also brings a wealth of experience in regulatory affairs concerning development of new biomedical products.
"I am delighted to join the outstanding team at Althea and to contribute to their continued growth," stated Mr. Moore. "I have been following Althea's progress over the last three years and have been particularly impressed with how well Althea has positioned itself in a number of key service and contract manufacturing areas. I am looking forward to introducing Althea's services and technologies on a broader scale, including internationally, and working to expand our collaborations and capabilities in areas that our pharmaceutical, biotech and government agency clients find valuable."
About Althea Technologies, Inc.
Althea provides technology access and a number of specialized services to support researchers worldwide in their attempts to understand the mechanisms of disease and to accelerate the development of new therapeutics. Althea's services include GLP and non-GLP gene expression analyses using its proprietary eXpress Profiling technology and real-time PCR, custom genomic analyses using real-time PCR, cGMP plasmid DNA and protein production, and formulation and fill services. For more information, visit www.altheatech.com.Contact:
| Althea Technologies, Inc. Alan Moore Executive Vice President & Chief Business Officer (858) 882-0205 amoore@altheatech.com |
Althea Technologies
A leading provider of contract services to
the pharmaceutical and biotechnology industries
11040 Roselle Street | San Diego, CA 92121-1205
Toll-free 1-888-4ALTHEA
info@altheatech.com